One rationale for centralisation was the thought that expanding the volume and variety of cases treated in larger cancer centres would address apparent regional inequalities in life expectancy [1, 4] . This was partly underpinned by an increasing number of international studies that showed a volume-outcome relationship in O-G cancer surgery [5] [6] [7] [8] . Moreover,
this relationship was observed across O-G cancer services in England between 2004 and 2008
by Coupland et al [9] . They reported that increasing hospital volume was strongly associated with lower postoperative mortality at 30 days.
This study was designed to investigate the changes in surgical activity and outcomes that have staging, peri-operative care, and the introduction of neoadjuvant and adjuvant oncology [11] .
In this study, we examined trends in (i) the numbers of NHS trusts performing curative surgery, (ii) the median patient volume of these trusts, (iii) the number of consultants performing surgery, and how these might be associated with changes in postoperative mortality after surgical resection at 30 days, 90 days and 1 year.
METHODS

Data source
Data on the inpatient care received by patients with O-G cancer in English NHS trusts was obtained from Hospital Episodes Statistics (HES), a hospital administrative database that contains records on all same day and overnight admissions to English NHS acute trusts.
Clinical information is captured using the International Classification of Disease (ICD-10) diagnostic codes and the Classification of Surgical Operations and Procedures (OPCS-4), but it lacks specific information about tumour characteristics (such as pathological stage) and cancer care (such as date of diagnosis). Records for the same individual are allocated the same anonymised identifier, which allows treatment pathways to be followed over time.
Patient cohort and characteristics
We identified all patients (aged 18 years and over) diagnosed with oesophageal or stomach cancer (ICD-10: C15 and C16) between 1 April 2003 and 31 March 2014, taking the first instance of these codes as the date of diagnosis. Variables were defined for patient age at diagnosis, sex, tumour type (oesophageal / stomach), and number of comorbidities.
Comorbidities were identified using the RCS Charlson score [12] , which covers 14 conditions known to be associated with the risk of postoperative mortality (the score includes categories for malignancy and metastatic tumours, and these were excluded when calculating the score in this study). Patients were labelled as having 0, 1, 2, and 3 or more comorbidities. A variable for socioeconomic deprivation was also defined using the 2004 Index of Multiple deprivation (IMD) [13] . We categorised the IMD score into ordered quintiles, with the first and fifth quintiles corresponding to the least and most deprived, respectively.
Services and treatments at NHS hospitals
Patients were flagged as having curative surgery if they underwent either oesophagectomy or gastrectomy (OPCS codes: G01, G02, G03-oseophageal resections; G27, G28-gastric resections). We flagged an NHS trust as performing curative surgery if it had performed more than five procedures in a financial year (April-March). Individual consultants were identified using the anonymised consultant code, and were counted as part of the O-G surgical team within an NHS trust if they had performed at least one operation in a year. The consultant codes were available from the 2005-06 financial year. Surgical volume at NHS trust and consultant level was defined as the total number of procedures performed in the financial year.
Over the study period, there was an increase in the combination of neoadjuvant chemotherapy and radiotherapy with surgery. As inpatient HES records do not capture information about the provision of chemo/radiotherapy reliably, we used the time from diagnosis to surgery as a proxy marker for a patient having neoadjuvant therapy (Appendix, Figure A) . If the time from diagnosis to surgery was greater than 100 days, a patient was flagged as having neoadjuvant therapy and surgery; otherwise, they were flagged as having surgery alone.
Outcome variables
The primary outcomes were postoperative mortality at 30 days, 90 days or 1 year and was calculated for each patient as the difference between the date of operation and date of death.
The date of death was obtained from the Office for National Statistics Death Register, with patients identified using the same anonymised HESID used within the HES database. Dates of death were available until 16 October 2016, hence all patients had a minimum of 1 year follow up information . Length of postoperative hospital stay was defined as a secondary outcome and calculated as the difference between operation date and the discharge date.
Statistical analysis
For each financial year, we derived the number of NHS trusts undertaking curative surgery, the number of consultants per NHS trust performing surgery, the annual number of operations performed at a trust, and the number of patients having surgery. The financial years were labelled as the year in which they begin.
Patient characteristics were described using proportions, with continuous variables being categorised to show the skewness of the distributions. The analysis was undertaken using year of operation. We grouped the data into periods for presentation only. The association between year of operation and categorical variables were assessed using chi-squared tests, and the association between year of operation and continuous variables were assessed using linear regression where the year of operation was defined as a linear term.
Logistic regression models were used to examine the association between postoperative mortality (at 30 day, 90 day and 1 year), trust volume, and patient variables (age, sex, type of cancer, comorbidities, social deprivation, and whether or not a patient was flagged as having neoadjuvant therapy). Estimates were derived with robust standard errors to account for the clustering of patients within NHS trusts.
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Adjusted mortality rates for each financial year were derived by dividing the observed deaths by the number expected multiplied by the mean rate over the study period. A predicted risk of death for each patient was derived from multivariable logistic regression models and summed up for each year to create the expected number [14] . All statistical tests were two-sided, with p-values of less than 0.05 indicating a significant result. The analyses were performed using STATA® version 14 (StataCorp, College Station, Texas, USA).
RESULTS
Changes in trust and consultant volumes
Between Table 1 in Appendix for full details). Table 1 shows the characteristics of patients who had curative surgery over the study period.
Profile of patient characteristics
For both oesophageal and gastric cancer patients, patients undergoing surgery as a proportion of all patients diagnosed decreased with increasing age and was lower among women compared to men (Table 1) . Although the quality of coding of co-morbidities has improved with time, there is no evidence to suggest that patients with more co-morbidities were less likely to have surgery.
The change in the organisation of surgery did not appear to have resulted in large changes in the characteristics of patients being selected for surgery (Table 1) . Over time, the proportions of patients having surgery remained stable across the age categories, by gender, and for increasing numbers of comorbidities. The distribution of surgical patients with oesophageal tumours across the deprivation quintiles was also little changed. 
Relationship between outcomes and other factors
Previous work and what our study adds
Our results show that the period of centralisation of O-G cancer surgery has achieved the desired outcome of higher surgical volumes in NHS trusts, and that the NHS is now delivering better patient outcomes. Studies done at the local level in the UK support these high level findings but, like this study, they have been unable to disentangle the complex relationships between changes in hospital and surgeon volume, improvements in medical care
(oncological treatments, staging and advances in intensive care) and patient outcomes. In relation to the process of care, the surgical centralisation of O-G cancer services in South East
Wales was reported to result in a manageable workload that offered a substantial increase in cancer-related operative training opportunities [16] . Another study from Wales showed that oesophageal cancer patients treated by multi-disciplinary teams experienced a lower postoperative mortality than control patients, and were more likely to survive 5 years (p<0.001) [17] . An organisational survey on the progress due to centralisation has shown that targets of minimum staffing levels have been achieved and the use of formal assessment of nutritional needs has improved [18] . In relation to the outcomes of surgery, a study examining the effect centralisation on O-G cancer services in Gloucester reported improvement in the median survival time and substantial reductions in 30 day post-operative mortality from 10.3% precentralisation to 3.6% post-centralisation (p = 0.006) [19] . Experiences from abroad have been similar. Work conducted in the Netherlands demonstrate comparable improvements to those observed in our study [20] .
Strengths and Limitations
The main strength of the study comes from its comprehensive coverage of all English NHS acute trusts. Its principal limitations arise from the use of routine administrative hospital data.
First, HES lacked cancer-related clinical information such as the date of cancer diagnosis.
We used the admission date of the first O-G cancer related admission as a proxy for the date of diagnosis. This will introduce some error in the time from diagnosis to surgery but it is M A N U S C R I P T
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regarded as a robust method of approximation. Second, the estimates of surgical volume rely on the accurate coding of oesophageal and gastric resections. However, work comparing records of O-G cancer patients in HES and the National O-G cancer audit found excellent levels of agreement in use of the appropriate OPCS procedure codes for O-G surgical resection [21] . As a result, we expect the overall effect of coding errors to be small.
Third, the HES database does not contain data on patient characteristics that could influence their postoperative outcome such as histology, stage of disease, and frailty [22] . The omission of these factors from the risk adjustment model could have reduced its explanatory power, but there is no evidence for these characteristics having changed greatly over study period. Consequently, it seems this is unlikely to account for the observed changes in postoperative mortality over time. 
Conclusion
The results of this study reveal the large change in the delivery of curative surgery to patients 
